Flavonoids, the emerging dietary supplement against cisplatin-induced nephrotoxicity

Chemico-Biological Interactions

Volumn 248, Issue , 2016, Pages 18-20

  Athira, K V ^a   Madhana, Rajaram Mohanrao ^a   Lahkar, Mangala ^a,b  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b GAUHATI MEDICAL COLLEGE   (India)

Author keywords

Cancer; Cisplatin; Flavonoids; Nephrotoxicity

Indexed keywords

APIGENIN; AURANTIIN; CISPLATIN; DOCETAXEL; FISETIN; FLAVONOID; FLUOROURACIL; ISOLIQUIRITIGENIN; LICOCHALCONE A; PHOSPHATIDYLINOSITOL 3 KINASE; PLACEBO; PROTEIN KINASE B; PROTEIN P53; QUERCETIN; SILIBININ; SILYMARIN; TANGERETIN; WOGONIN; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; FLAVANONE DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; COLON CARCINOMA; DIET SUPPLEMENTATION; EMBRYONAL CARCINOMA; ENZYME ACTIVITY; HUMAN; KIDNEY DYSFUNCTION; NEPHROTOXICITY; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROMYELOCYTIC LEUKEMIA; RENAL PROTECTION; SOLID TUMOR; TRIPLE NEGATIVE BREAST CANCER; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; KIDNEY; KIDNEY DISEASE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CISPLATIN; FLAVANONES; KIDNEY; KIDNEY DISEASES;

EID: 84958755717     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2016.02.005     Document Type: Letter

References (22)

1. Y. Chtourou, B. Aouey, S. Aroui, M. Kebieche, and H. Fetoui Anti-apoptotic and anti-inflammatory effects of naringin on cisplatin-induced renal injury in the rat Chem. Biol. Interact. 243 2016 1 9 10.1016/j.cbi.2015.11.019
2. T.-G. Ahn, H.-K. Kim, S.-W. Park, S.-A. Kim, B.-R. Lee, and S.J. Han Protective effects of green tea polyphenol against cisplatin-induced nephrotoxicity in rats Obstet. Gynecol. Sci. 57 2014 464 470 10.5468/ogs.2014.57.6.464
3. R. Hamad, C. Jayakumar, P. Ranganathan, R. Mohamed, M.M. El-Hamamy, A.A. Dessouki, A. Ibrahim, and G. Ramesh Honey feeding protects kidney against cisplatin nephrotoxicity through suppression of inflammation Clin. Exp. Pharmacol. Physiol. 42 2015 843 848 10.1111/1440-1681.12433
4. K.M. Kamel, A. El-Raouf, M. Ola, S.A. Metwally, A. El-Latif, A. Hekma, and M.E. El-sayed Hesperidin and rutin, antioxidant citrus flavonoids, attenuate cisplatin-induced nephrotoxicity in rats J. Biochem. Mol. Toxic. 28 2014 312 319 10.1002/jbt.21567
5. O.A. Almaghrabi Molecular and biochemical investigations on the effect of quercetin on oxidative stress induced by cisplatin in rat kidney Saudi J. Biol. Sci. 22 2015 227 231 10.1016/j.sjbs.2014.12.008
6. B.D. Sahu, A.K. Kalvala, M. Koneru, J.M. Kumar, M. Kuncha, S.S. Rachamalla, and R. Sistla Ameliorative effect of fisetin on cisplatin-induced nephrotoxicity in rats via modulation of NF-κB activation and antioxidant defence PLoS ONE 9 2014 e105070 10.1371/journal.pone.0105070
7. S.M. Ju, J.G. Kang, J.S. Bae, H.O. Pae, Y.S. Lyu, and B.H. Jeon The flavonoid apigenin ameliorates cisplatin-induced nephrotoxicity through reduction of p53 activation and promotion of PI3K/Akt pathway in human renal proximal tubular epithelial cells Evid. Based Complement. Altern. Med. 2015 2015 10.1155/2015/186436
8. F. Shahbazi, S. Dashti-Khavidaki, H. Khalili, and M. Lessan-Pezeshki Potential renoprotective effects of silymarin against nephrotoxic drugs: a review of literature J. Pharm. Pharm. Sci. 15 2012 112 123
9. A. Momeni, A. Hajigholami, S. Geshnizjani, and S. Kheiri Effect of silymarin in the prevention of cisplatin nephrotoxicity, a clinical trial study J. Clin. Diagn. Res. 9 2015 11 13 10.7860/JCDR/2015/12776.5789
10. F. Shahbazi, S. Sadighi, S. Dashti-Khavidaki, F. Shahi, M. Mirzania, A. Abdollahi, and M.H. Ghahremani Effect of silymarin administration on cisplatin nephrotoxicity: report from a pilot, randomized, double-blinded, placebo-controlled clinical trial Phytother. Res. 29 2015 1046 1053 10.1002/ptr.5345
11. M. Fantini, M. Benvenuto, L. Masuelli, G.V. Frajese, I. Tresoldi, A. Modesti, and R. Bei In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatment Int. J. Mol. Sci. 16 2015 9236 9282 10.3390/ijms16059236
12. M.L. Smith, K. Murphy, C.D. Doucette, A.L. Greenshields, and D.W. HoskinSmith The dietary flavonoid fisetin causes cell cycle arrest, caspase-dependent apoptosis, and enhanced cytotoxicity of chemotherapeutic drugs in triple-negative breast cancer cells J. Cell. Biochem. 9999 2016 1 13 10.1002/jcb.25490
13. R. Tripathi, T. Samadder, S. Gupta, A. Surolia, and C. Shaha Anticancer activity of a combination of cisplatin and fisetin in embryonal carcinoma cells and xenograft tumors Mol. Cancer Ther. 10 2011 255 268 10.1158/1535-7163.MCT-10-0606
14. W. Zhuo, L. Zhang, Y. Zhu, B. Zhu, and Z. Chen Fisetin, a dietary bioflavonoid, reverses acquired cisplatin-resistance of lung adenocarcinoma cells through MAPK/Survivin/Caspase pathway Am. J. Transl. Res. 7 2015 2045
15. G. Scambia, F. Ranelletti, P.B. Panici, G. Bonanno, R. De Vincenzo, M. Piantelli, and S. Mancuso Synergistic antiproliferative activity of quercetin and cisplatin on ovarian cancer cell growth Anti Cancer Drugs 1 1990 45 48
16. L. Čipák, P. Rauko, E. Miadoková, I. Čipáková, and L. Novotný Effects of flavonoids on cisplatin-induced apoptosis of HL-60 and L1210 leukemia cells Leuk. Res. 27 2003 65 72 10.1016/S0145-2126(02)00063-2
17. E.-S.A. Arafa, Q. Zhu, B.M. Barakat, G. Wani, Q. Zhao, M.A. El-Mahdy, and A.A. Wani Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway Cancer Res. 69 2009 8910 8917 10.1158/0008-5472.CAN-09-1543
18. J.W. Kim, E.H. Kim, J.Y. Park, M. Kwon, and J.-L. Roh Wogonin overcomes cisplatin resistance of head and neck cancer by targeting antioxidant defense mechanisms Cancer Res. 75 2015 10.1158/1538-7445.AM2015-5454 5454-5454
19. C.K. Lee, S.H. Son, K.K. Park, J.H.Y. Park, S.S. Lim, and W.Y. Chung Isoliquiritigenin inhibits tumor growth and protects the kidney and liver against chemotherapy-induced toxicity in a mouse xenograft model of colon carcinoma J. Pharmacol. Sci. 106 2008 444 451 10.1254/jphs.FP0071498
20. C.K. Lee, S.H. Son, K.K. Park, J.H.Y. Park, S.S. Lim, S.H. Kim, and W.Y. Chung Licochalcone A inhibits the growth of colon carcinoma and attenuates cisplatin-induced toxicity without a loss of chemotherapeutic efficacy in mice Basic Clin. Pharmacol. Toxicol. 103 2008 48 54 10.1111/j.1742-7843
21. P.D. Sanchez-Gonzalez, F.J. Lopez-Hernandez, F. Perez-Barriocanal, A.I. Morales, and J.M. Lopez-Novoa Quercetin reduces cisplatin nephrotoxicity in rats without compromising its anti-tumour activity Nephrol. Dial. Transpl. 195 2011 1 12 10.1093/ndt/gfr195
22. C. Bokemeyer, L. Fels, T. Dunn, W. Voigt, J. Gaedeke, H. Schmoll, H. Stolte, and H. Lentzen Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity Br. J. Cancer 74 1996 2036 2041